Understanding how amyloid-beta interacts with inflammasome proteins
Mechanisms of NLRP3 inflammasome activation
['FUNDING_R15'] · UNIVERSITY OF MISSOURI-ST. LOUIS · NIH-11036891
This study is looking at how certain proteins related to inflammation interact with amyloid-beta, which is important for understanding diseases like Alzheimer's, and it also helps students learn new scientific skills along the way.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSOURI-ST. LOUIS (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11036891 on ClinicalTrials.gov |
What this research studies
This research investigates the interactions between amyloid-beta peptides and proteins that make up the NLRP3 inflammasome, which is involved in inflammatory responses in the body. Using advanced imaging technology, the study aims to characterize how these interactions influence inflammasome function. The research will enhance the training of undergraduate students at the University of Missouri-St. Louis, allowing them to engage in cutting-edge scientific techniques. The findings could provide insights into the mechanisms underlying neurodegenerative diseases like Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals under 20 years of age who may be at risk for or affected by Alzheimer's disease or related conditions.
Not a fit: Patients over 20 years of age or those not affected by Alzheimer's disease may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of Alzheimer's disease mechanisms and potentially inform new therapeutic strategies.
How similar studies have performed: Previous research has shown promise in understanding the role of inflammasomes in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
SAINT LOUIS, UNITED STATES
- UNIVERSITY OF MISSOURI-ST. LOUIS — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NICHOLS, MICHAEL R. — UNIVERSITY OF MISSOURI-ST. LOUIS
- Study coordinator: NICHOLS, MICHAEL R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.